Short-term risk of falls among initiators of controlled-release tapentadol versus oxycodone in New South Wales between 2014 and 2020: A population-based retrospective cohort study
by Ximena Camacho, Andrea L. Schaffer, Jonathan Brett, Ria Hopkins, Natasa Gisev, Steven Marsh, Kristian B. Filion, Nicole Pratt, David Henry, Sallie-Anne Pearson Background Clinical trials comparing sustained-release (SR) tapentadol with controlled-release (CR) oxycodone have suggested that tapentadol (SR) may be associated with fewer nervous system side effects. However, it remains important to…
Durability is perhaps the single-biggest hesitation about folding phones, but Samsung has proven time and time again that its foldables are rather strong and resilient.
Scientists exploring seamounts off the coast of Costa Rica have discovered a new coral so genetically and morphologically distinct that it required the creation of an entirely new family for its…
Antisense oligonucleotides (ASOs) have been proposed as a therapeutic approach to shut down the production of faulty proteins in a wide variety of diseases, including cancer.